MORRISVILLE, N.Y. (AP) — MORRISVILLE, N.Y. (AP) — TG Therapeutics Inc. (TGTX) on Monday reported third-quarter net income of $390.9 million.
On a per-share basis, the Morrisville, New York-based company said it had profit of $2.43.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 24 cents per share.
The biopharmaceutical company posted revenue of $161.7 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $150.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TGTX at https://www.zacks.com/ap/TGTX
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
